iRhythm Holdings, Inc. Common Stock (IRTC) — 分析摘要
iRhythm Holdings, Inc. Common Stock(IRTC)的市值为3.90十亿美元,最近一年的营收同比增长了+26.2%。净利润率为-6.0%。当前市盈率为-140.4倍。
核心要点
- 营收同比变化+26.2%
- 净利润率-6.0%
- 市盈率-140.4倍
与SURGICAL & MEDICAL INSTRUMENTS & APPARATUS板块的其他公司相比,IRTC的营收增长为+26.2%,市盈率为-140.4倍。
iRhythm Holdings, Inc. Common Stock (IRTC)
更新 — ET · 来源 POLYGON
红旗与风险提示高风险信号
存在多项实质性红旗,在依赖任何估值输出前应先重点核查这些风险。
利息保障倍数为 -3.1x — 盈利不足以覆盖利息支出
D/E 为 4.0x — 财务杠杆偏高
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
行业
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
员工人数
2,400
总部
San Francisco, CA
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。